DDMAC HOME PAGE WILL CARRY QUARTERLY REVIEW OF REGULATORY LETTER ISSUES; INDUSTRY SHOULD RETHINK AD PRECLEARANCE FOR LAUNCHES, J&J's PATTERSON SAYS
Executive Summary
FDA's Division of Drug Marketing, Advertising and Communications Internet home page will contain a quarterly review of advertising regulatory actions, DDMAC Public Health Advisor Melissa Moncavage told a Food & Drug Law Institute meeting May 21 in Washington, D.C.